Preventing Diabetes and Atherosclerosis in Sub-Saharan Africa: Should the Metabolic Syndrome Have a Role?
Preventing Diabetes and Atherosclerosis in Sub-Saharan Africa: Should the Metabolic Syndrome Have a Role?
复制标题
DOI：
10.1007/s12170-009-0026-7
复制
发表时间：
2009-05-01
影响因子：
1.9
通讯作者：
Sumner, Anne E.
中科院分区：
文献类型：
--
作者：
Imoisili, Omoye E.;Sumner, Anne E.
肥胖、高血压、动脉粥样硬化和2型糖尿病在撒哈拉以南非洲所有地区都在增加。代谢综合征是预测欧洲和北美人群动脉粥样硬化和2型糖尿病的一个有价值的工具。然而，代谢综合征在非洲人群中的适用性尚未得到研究。在将稀缺的资金投入代谢综合征的诊断和治疗之前，需要设计初步研究，以确定代谢综合征的患病率及其在非洲发现早期可治疗疾病的能力。通过对这些数据的评估，我们可以确定将代谢综合征作为一个整体来关注更有效，还是将肥胖、高血压、动脉粥样硬化和2型糖尿病作为个体来关注更有效。本文概述了撒哈拉以南非洲东部、西部和南部地区代谢综合征变量的表现。
Obesity, hypertension, atherosclerosis, and type 2 diabetes mellitus are increasing in all regions of sub-Saharan Africa. The metabolic syndrome is a valuable tool in predicting atherosclerosis and type 2 diabetes in populations in Europe and North America. However, the applicability of the metabolic syndrome to African populations has not been studied. Prior to investing scarce funds into diagnosing and treating the metabolic syndrome, primary research needs to be designed to determine the prevalence of the metabolic syndrome and its ability to detect early, treatable disease in Africa. Assessment of these data should make it possible to determine if it is more effective to focus on the metabolic syndrome as a whole or on obesity, hypertension, atherosclerosis, and type 2 diabetes as individual conditions. This article is an overview of the presentation of metabolic syndrome variables in the Eastern, Western, and Southern regions of sub-Saharan Africa.